Allopurinol dual-release preparation and preparation method thereof

A dual-release, allopurinol technology, applied in pill delivery, pharmaceutical formulations, medical preparations of non-active ingredients, etc., can solve the problem of short action time, inability to maintain stable and effective anti-gout blood drug concentration, and easy occurrence of adverse reactions, etc. question

Active Publication Date: 2011-06-15
COSCI MED TECH CO LTD
View PDF0 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, allopurinol that has been marketed in China is an ordinary tablet, which generally needs to be taken 1 to 3 times a day, and it cannot maintain a stable and effective anti-gout blood

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Allopurinol dual-release preparation and preparation method thereof
  • Allopurinol dual-release preparation and preparation method thereof
  • Allopurinol dual-release preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] quick release part

[0027] Allopurinol 50g

[0028] Microcrystalline Cellulose 101 20g

[0029] Starch 30g

[0030] Povidone K30 3g

[0031] Magnesium stearate 0.5g

[0032] Sustained release part

[0033] Allopurinol 200g

[0034] Hypromellose K100LV 40g

[0035] Microcrystalline Cellulose 101 50g

[0036] Povidone K30 15g

[0037] Magnesium stearate 0.8g

[0038]

[0039] Made into 1000 pieces / grain

[0040] Preparation:

[0041] (1) Preparation of immediate-release granules: crush allopurinol through an 80-mesh sieve, and set aside; weigh allopurinol, starch, povidone K30, and microcrystalline cellulose 101 of the prescribed amount, mix well, add appropriate amount of water, and carry out Wet granulation, wet granulation with a 16-mesh sieve, drying at 50°C, granulation with a 20-mesh sieve, calculate the yield, add magnesium stearate, mix, and set aside.

[0042] (2) Preparation of sustained-release granules: cr...

Embodiment 2

[0046] Quick release part:

[0047] Allopurinol 50g

[0048] Microcrystalline Cellulose 101 25g

[0049] Starch 26g

[0050] Povidone K30 3.7g

[0051] Magnesium stearate 0.5g

[0052] Sustained release part

[0053] Allopurinol 200g

[0054] Hypromellose K4M 25g

[0055] Hypromellose E5 26g

[0056] Microcrystalline Cellulose 101 45g

[0057] Povidone K30 15g

[0058] Magnesium stearate 0.8g

[0059]

[0060] Made into 1000 pieces / grain

[0061] Preparation method: with embodiment 1.

Embodiment 3

[0063] Quick release part:

[0064] Allopurinol 125g

[0065] Microcrystalline Cellulose 101 38g

[0066] Sodium carboxymethyl starch 23g

[0067] Povidone K 30 12g

[0068] Magnesium Stearate 1g

[0069] Sustained release part:

[0070] Allopurinol 125g

[0071] Hypromellose K100LV 55g

[0072] Microcrystalline Cellulose 101 40g

[0073] Povidone K 30 15g

[0074] Magnesium Stearate 1g

[0075]

[0076] A total of 1000 pieces / grain

[0077] Preparation method: with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an allopurinol dual-release preparation and a preparation method thereof, which is characterized in that the dual-release preparation consists of a quick-release part and a slow-release part, wherein the ratio of the base allopurinol contained in the quick-release part to the base allopurinol contained in the slow-release part is 1:1 to 1:24. The invention belongs to the technical field of medicine preparation and aims at providing the allopurinol dual-release preparation with good patient compliance and small side effect and the preparation method thereof, wherein the allopurinol dual-release preparation has the advantages of taking effect quickly and maintaining effective blood concentration stably. The dual-release preparation can not only be used for reducing the side effect on the gastrointestinal tract, but also decreasing the administration times of a patient and adverse effect and promoting the patient compliance.

Description

technical field [0001] The invention relates to an allopurinol double-release preparation and a preparation method thereof, which is characterized in that the double-release preparation is composed of an immediate-release part and a sustained-release part, wherein the immediate-release part and the sustained-release part contain the main drug allopurinol The specific gravity is 1:1-1:24. It belongs to the technical field of pharmaceutical preparations. Background technique [0002] Allpurinol has a chemical structure of 1H-pyrazolo[3,4-d]pyrimidin-4-ol. Allopurinol is white or off-white crystalline powder; almost odorless and tasteless. Very slightly soluble in water or ethanol, insoluble in ether or chloroform; dissolved in alkaline solution. Allopurinol is currently the only drug that can inhibit the synthesis of uric acid. It and its metabolite oxypurinol inhibit the activity of xanthine oxidase, prevent the metabolism of hypoxanthine and xanthine into uric acid, and r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/24A61K9/52A61K31/519A61K47/38A61P19/06
Inventor 蒋海松张扬
Owner COSCI MED TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap